期刊文献+

RP-HPLC测定西洛他唑的血药浓度及药动学研究 被引量:3

Determination of Cilostazol in Human Plasma by RP-HPLC:Application to Its Pharmacokinetics
暂未订购
导出
摘要 目的建立RP-HPLC测定人血浆中西洛他唑含量,并研究西洛他唑片在健康人体内的药动学.方法色谱柱为HypersilODS-2(4.6 mm×150mm,5 μm)柱,流动相为乙腈-水(45:55),流速1.0mL·min^-1,柱温35℃,检测波长254 nm.结果西洛他唑在25~2 000μg·L^-1内线性关系良好(r=0.999 2),血浆最低检测浓度为10μg·L^-1,日内及日间RSD均小于6%,在3种不同浓度下,平均回收率分别为102.71%,102.03%和99.01%.人体药动学研究表明,药-时曲线符合二房室模型,主要药动学参数tmax3.7 h,ρmax749.2μg·L^-1,AUC0~4810088.5μg·h·L^-1,t1/2α2.5 h,t1/2β11.9 h.结论此法简便、灵敏、准确、稳定,可用于药物分析,其药动学参数可为临床合理用药提供理论依据. OBJECTIVE To establish a reversed phase HPLC method for the detemination of eilustazul in human plasma and Io study its phannacokineties in healthy voluntcers. METHODS A hypersil ODS-2 column(4.6 mm× 150mm, 5μm)was used.The mobile phase consisted of aeetonitrile-water(45:55) with a flow rate of 1.0 mL·min^-1, and Ihe ultraviloet wavelength was at 254 nm. RESULTS The calibration curve was linear over the range of 25 - 2 000μg·L^-1( r- 0.999 2)and the quantitative limit was 10μg·L^-1. The intra- and inter-assay coeffieient of variation were less than 6% at all levels. The average recoveries were 102.71%, 102.03% and 99.01%, respectively. The plasma concentration-lime course followed a 2-compartment open model and its main pharmacokinetic paramelers were as fullows: tmax3.7 h,ρmax 749.2μg·L^-1 AUC0-48 10088.5μg·L^-1, t1/2α 2.5h, t1/2β 11.9 h. CONCLUSION This method is easy, sensitive, aeeurateand stable and is suitable for the pharamacokinetic study of cilostazol.
出处 《中国药学杂志》 CAS CSCD 北大核心 2006年第11期848-850,共3页 Chinese Pharmaceutical Journal
关键词 西洛他唑 高效液相色谱法 血药浓度 药动学 cilostazol HPLC plasma concentration pharmacokinctics
  • 相关文献

参考文献5

  • 1YAOH.Cilostazol:New treatment forintermittent claudication[J].中国药学杂志,2000,35(4):278-279.
  • 2KAMBAYASHI J,LIU Y,SUN B,et al.Cilostazol as a unique antithrombotic agent[J].CurrPharm Des,2003,9(28):2289-2291.
  • 3FUCJ,TATA P N,OKADA K,etal.Simultaneous quantitative determination of cilostazol andits metabolites in human plasma by highperformance liquid chromatography[J].J Chromatogr BBiomed Sci Appl,1999,28(2):251-262.
  • 4AKIYAMA H,KUDO S,ODOMI M,et al.High performance liquid chromatographic procedure forthe determination of a new antithrombotic and vasodilating agent,cilostazol,in humanplasma[J].J Chromatogr,1985,338(2):456-459.
  • 5BRAMER S L,FORBES W P,MALLIKAARJUN S.Cilostazol pharmacokinetics after single andmultiple oral doses in healthy males and patients with intermittent claudication resultingfrom peripheral arterial disease[J].Clin Pharmacokinet,1999,37(S2):1-11.

同被引文献2125

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部